Gene transfer therapy for neurodegenerative disorders
β Scribed by Andrew Feigin; David Eidelberg
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 120 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Recent advances in gene transfer technology have led to promising new therapies for neurodegenerative disorders. This article will review methods of gene transfer therapy and applications of these techniques to both genetic and sporadic neurodegenerative illnesses. The article will focus on Parkinson's disease, Huntington's disease, and Alzheimer's disease. Several promising gene therapy approaches to these diseases are being pursued both in animal models and in early human trials. Initial safetyβtolerability results from these trials appear promising. It is therefore likely that the number of human trials of gene therapy for neurodegenerative disorders will increase over the coming years. Β© 2007 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Mounting evidence suggests a central role for transition biometals in the etiopathogenesis of neurodegenerative diseases (ND). Indeed, while studying the molecular basis for this heterogeneous group of diseases, it has become increasingly evident that biometals and nonphysiological Al a
In a review article Miller [1] reported on the state of the art of human gene therapy as it was summarized in a meeting at the end of December 1991. The human trials in which human genes were successfully transferred in vitro to mark cells of patients and for gene therapy of genetic disorders. The a